Credit Suisse Ag Intercept Pharmaceuticals, Inc. Call Options Transaction History

Credit Suisse Ag

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $630,960 - $1.37 Million	-11,000 Reduced 55.0%	9,000 $1.12 Million
Q3 2019 Nov 12, 2019	BUY	$58.69 - $80.46 $1.17 Million - $1.61 Million	20,000 New	20,000 $1.33 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.